Trial Profile
Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Olanzapine (Primary) ; Olanzapine (Primary) ; Haloperidol; Haloperidol; Haloperidol
- Indications Delirium
- Focus Therapeutic Use
- 06 Apr 2017 Status changed from recruiting to completed.
- 08 Dec 2015 Planned End Date changed from 1 Aug 2015 to 1 Aug 2016, as reported by ClinicalTrials.gov.
- 08 Dec 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Aug 2016, as reported by ClinicalTrials.gov.